Abstract
While controlled ovarian hyperstimulation followed by IVF and cryopreservation of embryos is the most common and successful approach to fertility preservation for reproductive-age females diagnosed with cancer, there are many cases in which this approach may not be appropriate or possible. For some patients, a delay in cancer treatment for hormone treatment and egg retrieval is not acceptable, for others, hormone treatment may be contraindicated (e.g., for prepubertal patients and those with hormone-sensitive cancers), or they may not have a partner or willing sperm donor. Still other patients may have religious or moral objections to creating embryos. For these patients, ovarian tissue cryopreservation is an alternative option that does not require ovarian hyperstimulation or sperm. Cryopreserved tissue may be retransplanted into the patient at a later date to recover endocrine function and/or restore fertility. This chapter discusses the techniques required for ovarian tissue removal, cryopreservation, and transplantation and reviews current literature on outcomes of these procedures. While ovarian tissue cryopreservation and transplantation are considered experimental approaches, they are the only option for certain patients and need to be included in discussions about fertility preservation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
National Center for Health Statistics. 2010. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026210.pdf. Accessed 10 Nov 2011.
Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10:251–66.
Partridge AH, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174–83.
Zeltzer L. Cancer in adolescents and young adults psychosocial aspects. Long-term survivors. Cancer. 1993;71:3463–8.
Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622–8.
Jemal A, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.
Prest SJ, May FE, Westley BR. The estrogen-regulated protein, TFF-1, stimulates migration of human breast cancer cells. FASEB J. 2002;1(6):592–4.
Allerd CD, et al. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 2001;61:5045–50.
Embryo Bank. 2011. http://www.ivf-worldwide.com/Education/embryo-bank.html. Accessed 10 Nov 2011.
Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol. 2005;17:299–308.
Fauser B. Follicle pool depletion: factors involved and implications. Fertil Steril. 2000;74:629–30.
Oktem O, Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agent on human primordial follicle reserve. Cancer Res. 2007;67:10159–62.
Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2008;90:S241–6.
Silber S, Gosden RG. Ovarian transplantation in a series of monozygotic twins discordant for ovarian failure. N Engl J Med. 2007;356:1382–4.
Silber S, et al. Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril. 2010;94:2191–6.
Radford JA, et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin’s lymphoma. Lancet. 2001;357:1172–5.
Tryde Schmidt KL, et al. Orthotopic autotransplantation of cryopreserved ovarian tissue to a woman cured of cancer—follicular growth, steroid production and oocyte retrieval. Reprod Biomed Online. 2004;8:448–53.
Oktay K, et al. A technique for transplantation of ovarian cortical strips to the forearm. Fertil Steril. 2003;80:193–8.
Oktay K, et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA. 2001;286:1490–3.
Donnez J. Laparascopic ovarian tissue transplantation in humans. Gunaikeia. 2003;8:168.
Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv. 2006;62:58–72.
Lee DM, et al. Live birth after ovarian tissue transplant. Nature. 2004;428:137–8.
Rosendahl M, et al. Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: a case report. Hum Reprod. 2006;21:2006–9.
Oktay K. Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there a germline cell connection? Hum Reprod. 2006;21:1345–8.
Imhof M, et al. Cryopreservation of a whole ovary as a strategy for restoring ovarian function. J Assist Reprod Gen. 2004;21:459–65.
Bedaiwy MA, et al. Cryopreservation of intact human ovary with its vascular pedicle. Hum Reprod. 2006;21:3258–69.
Silber SJ, et al. A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation. Hum Reprod. 2008;23:1531–7.
Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301:527–30.
Donnez J, et al. Restoration of ovarian function after allografting of ovarian cortex between genetically non-identical sisters. Hum Reprod. 2010;25:2489–95.
Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med. 2000;342:1919.
Meirow D, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005;353:318–21.
Donnez J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405–10.
Demeestere I, et al. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist. 2007;12: 1437–42.
Demeestere I, et al. Birth of a second healthy girl more than 3 years after cryopreserved ovarian graft. Hum Reprod. 2010;25:1590–1.
Andersen CY, et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod. 2008;23:2266–72.
Ernst E, et al. The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue. Hum Reprod. 2010;25:1280–1.
Roux C, et al. Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation. Fertil Steril. 2008;93:2413.e15–e19.
Sánchez-Serrano M, et al. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Hum Reprod. 2010;93:e11–3.
Donnez J, et al. Pregnancy and live birth after autotransplantation of frozen-thawed ovarian tissue in a patient with metastatic disease undergoing chemotherapy and hematopoietic stem cell transplantation. Fertil Steril. 2011;95:e1–4.
Donnez J, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med. 2011;43:437–50.
Oktay K, Tilly J. Livebirth after cryopreserved ovarian tissue autotransplantation. Lancet. 2004;364:2091–2. author reply 2092–2093.
Bedaiwy MA, et al. Reproductive outcome after transplantation of ovarian tissue: a systematic review. Hum Reprod. 2008;23:2709–17.
Oktay K, Sonmezer M. Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation. Hum Reprod. 2004;19:477–80.
Kim S, et al. Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients. Fertil Steril. 2009;91:2349–54.
Donnez J, et al. The role of cryopreservation for women prior to treatment of malignancy. Curr Opin Obstet Gynecol. 2005;17:333–8.
Yada-Hashimoto N, et al. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol. 2003;89:314–7.
Dolmans MM, et al. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116:2908–14.
Kim SS, et al. Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod. 2001;16:2056–60.
Meirow D, et al. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod. 2001;16:632–7.
Hawkins MM. Pregnancy outcome and offspring after childhood cancer. BMJ. 1994;309:1034.
Sanders JE, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87: 3045–52.
Smitz J, et al. Current achievements and future research directions in ovarian culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update. 2010;16:395–414.
Acknowledgment
This work was supported by the Oncofertility Consortium NIH/NICHD 5UL1DE019587.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kondapalli, L.A. (2012). Ovarian Tissue Cryopreservation and Transplantation. In: Gracia, C., Woodruff, T. (eds) Oncofertility Medical Practice. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9425-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9425-7_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9424-0
Online ISBN: 978-1-4419-9425-7
eBook Packages: MedicineMedicine (R0)